Use of Cannabidiol and Cannabigerol in the Treatment of Trigeminal Neuralgia and Postherpetic Pain
Contemporary Clinical Dentistry · 2025-07 · 16 (3) · 199-201
DOI: 10.4103/ccd.ccd_280_24 ↗Kurz gefasst
Fallbericht in der Zeitschrift Contemporary Clinical Dentistry, online erschienen am 31.10.2025. Verfasst von Samara Ellen da Silva Souza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Christus University Center, Fortaleza, Brazil. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The use of cannabidiol (CBD) as an adjuvant in the treatment of trigeminal neuralgia (TN) and postherpetic neuropathy has shown beneficial effects in patients refractory to conventional treatments. This case study describes a 57-year-old patient diagnosed with TN in 2019, initially treated with low-power laser therapy and oxcarbazepine. In 2021, she developed vesicular-bullous lesions on the right side of the supraorbital region, accompanied by severe pain confirmed by positive serology for shingles. Following the diagnosis of postherpetic neuropathy, the drug dose was adjusted and combined with laser therapy. However, the pain remained significant and reduced quality of life. In 2023, treatment was started with CannaMeds CBD Full Spectrum – 3000 mg/30 ml + CannaMeds CBG Isolate 1500 mg/30 ml. After 15 days, the patient appeared pain-free, allowing the laser to be discontinued and the drug dose to be reduced. CBD is a treatment option for patients who do not respond to conventional treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Christus University Center, Fortaleza, Brazil.
- Department of Dentistry, Federal University of Ceará, Fortaleza, Brazil.
Zitieren
APA
Souza, S. E. D. S., Castro, A. B. B., Cavalcante, A. M. D. S., Gomes, A. K. P., Brizeno, L. A. C., Forte, C. P. F., & Dantas, T. S. (2025). Use of Cannabidiol and Cannabigerol in the Treatment of Trigeminal Neuralgia and Postherpetic Pain. Contemporary Clinical Dentistry, 16(3), 199-201. https://doi.org/10.4103/ccd.ccd_280_24
Vancouver
Souza SEDS, Castro ABB, Cavalcante AMDS, Gomes AKP, Brizeno LAC, Forte CPF, et al. Use of Cannabidiol and Cannabigerol in the Treatment of Trigeminal Neuralgia and Postherpetic Pain. Contemporary Clinical Dentistry. 2025;16(3):199-201. doi:10.4103/ccd.ccd_280_24
BibTeX
@article{Souza2025,
author = {Souza, Samara Ellen da Silva and Castro, Anny Beatriz Barbosa and Cavalcante, Ana Mirian da Silva and Gomes, Aghata Kelma Palacio and Brizeno, Luiz André Cavalcante and Forte, Clarissa Pessoa Fernandes and Dantas, Thinali Sousa},
title = {Use of Cannabidiol and Cannabigerol in the Treatment of Trigeminal Neuralgia and Postherpetic Pain},
journal = {Contemporary Clinical Dentistry},
year = {2025},
volume = {16},
number = {3},
pages = {199--201},
doi = {10.4103/ccd.ccd_280_24}
}
EUVIMED